ILMN

NASDAQ · Life Sciences Tools & Services

Illumina Inc

Large-Cap Stocks Blue Chip Stocks Healthcare Stocks

$141.88

+3.17 (+2.29%)

As of May 9, 1:06 AM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 15 54%

Hold 10 36%

Sell 3 11%

Price Target

Analyst Price Target +19.4% upside

Low Target $114.37

Average Target $169.36

High Target $229.23

Current Price $141.88

Current
$141.88

Target
$169.36

$114.37 $169.36 avg $229.23

Scenario Analysis

Bear Case

$114.37

-19.4%

Low target

Base Case

$169.36

+19.4%

Avg target

Bull Case

$229.23

+61.6%

High target

Risk/Reward

3.2x

Highly favorable

Price in Context

52-Week High

$155.53

-8.8% from high

52-Week Low

$73.86

+92.1% from low

50-Day SMA

$136.22

+4.2% vs SMA

200-Day SMA

$108.49

+30.8% vs SMA

RSI (14)

17.5

Oversold

Target vs 52W High

$169.36

+8.9% vs high

Peer Consensus — Life Sciences Tools & Services

Stock	Consensus	Analysts	Buy %	Target	Upside
TMO Thermo Fisher Scientific Inc	Strong Buy	34	88%	$369.21	-20.6%
DHR Danaher Corp	Strong Buy	30	87%	$158.11	-7.6%
WAT Waters Corp	Buy	28	57%	$189.60	-46.6%
A Agilent Technologies Inc	Strong Buy	28	79%	$64.69	-44.0%
IQV Iqvia Holdings Inc	Strong Buy	31	87%	$82.96	-53.6%
MTD Mettler-Toledo International	Hold	21	48%	$170.43	-84.8%
WST West Pharmaceutical Services	Strong Buy	23	78%	$136.24	-58.2%
ILMN Illumina Inc	Hold	28	54%	$169.36	+19.4%